Prevalence, Risk Factors and Course of Osteoporosis in Patients with Crohn's Disease at a Tertiary Referral Center

被引:9
|
作者
Hoffmann, Peter [1 ]
Krisam, Johannes [2 ]
Kasperk, Christian [3 ]
Gauss, Annika [1 ]
机构
[1] Univ Hosp Heidelberg, Dept Gastroenterol & Hepatol, INF 410, D-69120 Heidelberg, Germany
[2] Univ Hosp Heidelberg, Inst Med Biometry & Informat, Dept Med Biometry, INF 130-3, D-69120 Heidelberg, Germany
[3] Univ Hosp Heidelberg, Dept Endocrinol & Clin Chem, INF 410, D-69120 Heidelberg, Germany
关键词
bone mineral density; osteopenia; osteoporosis; Crohn's disease; inflammatory bowel disease; steroids; bisphosphonates; BONE-MINERAL DENSITY; INFLAMMATORY-BOWEL-DISEASE; METAANALYSIS; EPIDEMIOLOGY; DIAGNOSIS; THERAPY;
D O I
10.3390/jcm8122178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with Crohn's disease are at increased risk for fractures due to low bone mineral density (BMD). Real-world data are necessary to optimize surveillance and treatment strategies. Methods: Patients with Crohn's disease who underwent at least one dual-energy X-ray absorptiometry (DXA) scans were recruited. The primary study endpoints were (1) prevalence of osteoporosis, and (2) factors influencing changes of BMD. To identify potential risk factors for reduced BMD, Mann-Whitney U-test was used for ordinal and continuous variables and x(2)-tests for categorical variables. Results with p < 0.05 were included in a multivariable analysis. To identify potential factors influencing changes in BMD, a generalized linear mixed model was applied. Results: 39.9% of the patients were diagnosed with normal BMD, 40.2% with osteopenia, and 19.8% with osteoporosis. The main risk factors for osteoporosis were low body mass index (BMI), previous bowel resections and male sex. The main risk factors for reduced BMD during further along the disease course were steroid use, history of immunomodulator treatment, female sex and decreased BMI. Conclusion: Low BMI, previous bowel resections and male sex were the main risk factors for the development of osteoporosis. Steroid use reduced BMD even under anti-inflammatory therapy, underlining that they should be used with great care in that patient group.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
    Vahedi, Homayoun
    Momtahen, Shabnam
    Olfati, Golrokh
    Abtahi, Azadeh
    Hosseini, Sarah
    Kazzazi, Amir-Sadreddin
    Khademi, Hooman
    Rashtak, Shahrooz
    Khaleghnejad, Reza
    Tabrizian, Tahmineh
    Hamidi, Zohreh
    Nouraie, Mehdi
    Malekzadeh, Fatemeh
    Merat, Shahin
    Nasseri-Moghaddam, Siavosh
    Sotoudehmanesh, Rasoul
    Larijani, Bagher
    ARCHIVES OF IRANIAN MEDICINE, 2009, 12 (06) : 570 - 575
  • [2] Osteoporosis Complications in Crohn's Disease Patients: Factors, Pathogenesis, and Treatment Outlines
    Baban, Yaqot N.
    Edicheria, Christopher M.
    Joseph, Joseph
    Kaur, Parneet
    Mostafa, Jihan A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [3] Crohn's disease outcome in patients under azathioprine: A tertiary referral center experience
    Magro, Fernando
    Santos-Antunes, Joao
    Vilas-Boas, Filipe
    Rodrigues-Pinto, Eduardo
    Coelho, Rosa
    Ribeiro, Orquidea Silva
    Lopes, Susana
    Macedo, Guilherme
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (07): : 617 - 625
  • [4] Risk factors of mortality following hospital admission for Crohn's disease: A cohort study at a tertiary referral center in Taiwan
    Huang, Po-Han
    Lin, Wey-Ran
    Le, Puo-Hsien
    Lin, Cheng-Yu
    Chen, Chun-Wei
    Wu, Ren-Chin
    Hsu, Jun-Te
    Tsai, Wen-Sy
    Lai, Ming-Wei
    Hsieh, Sen-Yung
    Su, Ming-Yao
    Chiu, Cheng-Tang
    Kuo, Chia-Jung
    ADVANCES IN DIGESTIVE MEDICINE, 2024, 11 (02) : 81 - 87
  • [5] Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn's Disease at a Tertiary Care Center in Rio de Janeiro
    de Sa Brito Froes, Renata
    da Luz Moreira, Andre
    Carneiro, Antonio Jose de V.
    Moreira, Jessica P. L.
    Luiz, Ronir R.
    de Barros Moreira, Adriana Maria Hilu
    Monnerat, Camila Cesar
    de Souza, Heitor Siffert Pereira
    Carvalho, Ana Teresa Pugas
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (09) : 2925 - 2934
  • [6] Risk Factors for Osteoporosis in Crohn's Disease: Infliximab, Corticosteroids, Body Mass Index, and Age of Onset
    Azzopardi, Neville
    Ellul, Pierre
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : 1173 - 1178
  • [7] Bones and Crohn's - Risk factors associated with low bone mineral density in patients with Crohn's disease
    Siffledeen, JS
    Fedorak, RN
    Siminoski, K
    Jen, H
    Vaudan, E
    Abraham, N
    Seinhart, H
    Greenberg, G
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (03) : 220 - 228
  • [8] Predictors of adalimumab dose escalation in patients with crohn's disease at a tertiary referral center
    Cohen, Russell D.
    Lewis, Jeffrey R.
    Turner, Hannah
    Harrell, Laura E.
    Hanauer, Stephen B.
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (01) : 10 - 16
  • [9] Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experience
    Alotaibi, Yazeed
    Allehibi, Abed
    Almtawa, Abdullah
    Alotaibi, Nawaf
    Alghamdi, Adel
    Alrajhi, Saad
    Alqutub, Adel
    Aleid, Ahmad
    Alamr, Abdulrhman
    Al Ibrahim, Bashaar
    Alahmari, Mohammed
    Alhamidi, Hussam
    Ahmad, Shameem
    Alshammari, Fouad
    Almotawa, Fahad
    Altannir, Youssef
    Alghamdi, Ahmed
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2023, 11 (04) : 305 - 313
  • [10] Erythrocyte sedimentation rate as an osteoporosis risk factor in patients with active Crohn's disease
    Siggelkow, H.
    Cortis, J.
    Claus, Ch.
    Funke, M.
    Nolte, W.
    Huefner, M.
    Raddatz, D.
    OSTEOLOGIE, 2009, 18 (03) : 209 - 216